Amphastar Pharmaceuticals, Inc. (AMPH) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 37 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 5, 2026after close 36 8-K
Q2 FY2026Thu, Aug 6, 2026after close 37 8-K
Q1 FY2026Thu, May 7, 2026after close 37 8-K
Q4 FY2025Thu, Feb 26, 2026after close 57 8-K
Q3 FY2025Thu, Nov 6, 2025after close 37 8-K
Q2 FY2025Thu, Aug 7, 2025after close 38 8-K
Q1 FY2025Wed, May 7, 2025after close 37 8-K
Q4 FY2024Thu, Feb 27, 2025after close 58 8-K

What they guided beta

Q3 FY2026 "Share Buyback Program ​ On November 4, 2026, the Company’s Board of Directors authorized a $50 million increase to the Company’s share buyback program, which is expected to continue for an indefinite period of time." exhibit
Q3 FY2026 "The Company is developing multiple proprietary products with injectable, topical and intranasal dosage forms. ​ The Company’s proprietary pipeline also includes four in-licensed products including three proprietary peptides targeting oncology and ophthalmology indications, and a fully synthetic corticotropin compound designed to address inflammatory and autoimmune conditions. ​ Conference Call Information ​ The Company will hold a conference call to discuss its financial results today, November 5, 2026, at 2:00 p.m. Pacific Time. ​ To access the conference call, dial toll-free (877) 407-0989 o" exhibit
Q2 FY2026 "This was partially offset by: o The impact of lower average selling price for BAQSIMI ® , glucagon, and our epinephrine multi-dose vial product o Increased manufacturing expenses due to the expansion of our manufacturing facility in Rancho Cucamonga, CA ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ Change ​ ​ ​ 2026 ​ 2025 ​ Dollars ​ ​ ​ % ​ ​ ​ (in thousands) ​ ​ ​ Selling, distribution, and marketing ​ $ 13,335 ​ $ 10,235 ​ $ 3,100 ​ 30 % General and administrative ​ ​ 18,242 ​ ​ 13,991 ​ ​ 4,251 ​ 30 % Research and development ​ ​ 22,164 ​ ​ 20,080 ​ ​ 2,084" exhibit
Q2 FY2026 "This increase was partially offset by a decrease in material and supply expenses. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ ​ ​ ​ ​ ​ ​ June 30, ​ Change ​ ​ ​ 2026 ​ 2025 ​ Dollars ​ ​ ​ % ​ ​ ​ (in thousands) ​ ​ ​ Non-operating expenses: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Interest income ​ $ 2,287 ​ $ 1,921 ​ $ 366 ​ 19 % Interest expense ​ ​ (6,659) ​ ​ (6,281) ​ ​ (378) ​ 6 % Other income (expenses), net ​ ​ 3,187 ​ ​ 1,511 ​ ​ 1,676 ​ 111 % Total non-operating expenses, net ​ $ (1,185) ​ $ (2,849) ​ $ 1,664 ​ (58) % ​ The change in non-operating expenses, net, is primarily a result of " exhibit
Q2 FY2026 "The Company is developing multiple proprietary products with injectable, topical and intranasal dosage forms. ​ The Company’s proprietary pipeline also includes four recently in-licensed products including three proprietary peptides targeting oncology and ophthalmology indications, and a fully synthetic corticotropin compound designed to address inflammatory and autoimmune conditions. ​ Conference Call Information ​ The Company will hold a conference call to discuss its financial results today, August 6, 2026, at 2:00 p.m. Pacific Time. ​ To access the conference call, dial toll-free (877) 407" exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AMPH
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AMPH

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AMPH earnings date badge

HTML

<a href="https://veritasdata.dev/company/AMPH/"><img src="https://veritasdata.dev/embed/AMPH.svg" alt="AMPH earnings date" width="240" height="56"></a>

Markdown

[![AMPH earnings date](https://veritasdata.dev/embed/AMPH.svg)](https://veritasdata.dev/company/AMPH/)

Script

<script async src="https://veritasdata.dev/embed/AMPH.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AMPH"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.